Results 51 to 60 of about 5,561 (172)
Objective: To investigate the effect of switching from deferasirox dispersible tablet (DT) to deferasirox film-coated tablet (FCT) on serum ferritin (SF) levels in transfusion-dependent patients.
Ayşe Gonca Kaçar +8 more
core +1 more source
Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use
, 2017 AimDeferasirox is a new oral iron chelating agent with several cases reporting renal adverse events in recent years. Our aim was to identify the incidence of deferasirox-related Fanconi syndrome (FS) and its risk factors.
莊國璨;蔡宜蓉;盧孟佑;曹永魁 +1 more
core +1 more source
Pengaruh Deferasirox Terhadap Kadar T4 dan TSH Pada B-Thalassemia Mayor dengan Kadar Ferritin Tinggi
Sari Pediatri, 2016 Latar belakang. Iron overload pada pasien -thalassemia mayor terjadi akibat transfusi berulang. Pengendapan besi terjadi terutama di jantung, hati dan kelenjar endokrin.
Dewi Ratih P +2 more
doaj +1 more source
Journal of Microbiology and Infectious Diseases, 2016 In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal amphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery.
Uğur Onal +6 more
doaj +1 more source
The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR Β-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE
Mediterranean Journal of Hematology and Infectious Diseases, 2020 Background: The four most commonly used chelation regimens for β-thalassemia major patients in China are a combination therapy of deferoxamine and deferiprone (DFO+DFP), deferoxamine(DFO) monotherapy, deferiprone(DFP) monotherapy and deferasirox(DFX ...
Jialian Li
doaj +1 more source
, 2015 Paolo Ricchi,1 Maria Marsella1,2 1UOSD Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale “Antonio Cardarelli”, Naples, 2UOC Pediatria, Azienda Ospedaliera di Rilievo Nazionale G. Rummo, Benevento, Italy Abstract:
Ricchi P, Marsella M
core
Deferasirox származékok és komplexeik szintézise és vizsgálata
, 2020 A kutatómunka célja a deferasirox komplexek szintézise volt. Ligandumként alkalmazva a deferasiroxot feltételezéseink szerint kettős hatású komplexekhez juthatunk.
Ferenczik, Gergő Tamás
core
Deferasirox (Exjade) for the treatment of iron overload
, 2009 Deferasirox is a once-daily oral iron chelator with established dose-dependent efficacy in both adult and pediatric patients with transfusional iron overload.
A. Taher, M.D. Cappellini
core +1 more source
Deferasirox desensitization [PDF]
The Journal of Allergy and Clinical Immunology: In Practice, 2016 Karen E, Bruner, Kevin M, White
openaire +2 more sources
, 2018 Dijiong Wu,1 Xiaowen Wen,2 Wenbin Liu,1 Huijin Hu,1 Baodong Ye,1 Yuhong Zhou1 1Department of Hematology, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Internal ...
Wen X, Hu H, Ye B, Wu D, Zhou Y, Liu W
core